Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer


Weniger M., Moir J., Damm M., Maggino L., Kordes M., Rosendahl J., ...More

PANCREATOLOGY, vol.20, no.6, pp.1131-1138, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.1016/j.pan.2020.06.012
  • Title of Journal : PANCREATOLOGY
  • Page Numbers: pp.1131-1138

Abstract

Background: Neoadjuvant chemotherapy has become a powerful tool to convert borderline resectable (BRPC) and locally advanced pancreatic cancers (LAPC) into a resectable scenario. However, data analyzing the optimal type of therapy are scarce. In the present multicenter retrospective study, we evaluated the influence of FOLFIRINOX (FFX) and gemcitabine (GEM)-based neoadjuvant therapy on patient prognosis.